Teladoc Health Inc
SWB:4LL
Teladoc Health Inc
SWB:4LL
Price:
5.652
EUR
11.22%
Market Cap:
€6.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Teladoc Health Inc
SWB:4LL
|
US |
|
L
|
Lagardere SA
XBER:LAG
|
FR |
|
E
|
EnerSys
XMUN:FDN
|
US |
|
D
|
Dr Reddy's Laboratories Ltd
BSE:500124
|
IN |
|
B
|
BankUnited Inc
F:BNU
|
US |
|
Puuilo Oyj
F:8JQ
|
FI |
|
A
|
Ad Pepper Media International NV
XMUN:APM
|
DE |
|
Everbright Securities Co Ltd
F:0EC
|
CN |
|
S
|
Smith & Wesson Brands Inc
F:SWS
|
US |
|
O
|
Oil States International Inc
XBER:OI2
|
US |
|
M
|
McEwen Mining Inc
TSX:MUX
|
CA |
|
S
|
Spero Therapeutics Inc
F:2HA
|
US |
|
T
|
Teekay Tankers Ltd
F:3TKA
|
CA |
|
P
|
PIK Spetsializirovannyi Zastroyshchik PAO
MOEX:PIKK
|
RU |
|
Cellectis SA
PAR:ALCLS
|
FR |
Wall St Price Targets
4LL Price Targets Summary
Teladoc Health Inc
Teladoc Health Inc
Wall Street analysts forecast 4LL stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 4LL is 5.389 EUR with a low forecast of 3.785 EUR and a high forecast of 7.871 EUR.
Lowest Forecast
Price Target
3.785
EUR
33% Downside
Average Forecast
Price Target
5.389
EUR
5% Downside
Highest Forecast
Price Target
7.871
EUR
39% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4LL's stock price target?
Price Target
5.389
EUR
5.389
EUR
According to Wall Street analysts, the average 1-year price target for 4LL is 5.389 EUR with a low forecast of 3.785 EUR and a high forecast of 7.871 EUR.
What is the Revenue forecast for Teladoc Health Inc?
Projected CAGR
2%
2%
Over the last 11 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 6 years is 2%.
